- Previous Close
4.1560 - Open
4.1500 - Bid --
- Ask --
- Day's Range
4.1240 - 4.4000 - 52 Week Range
2.2600 - 12.6750 - Volume
171,527 - Avg. Volume
184,235 - Market Cap (intraday)
412.489M - Beta (5Y Monthly) 0.56
- PE Ratio (TTM)
-- - EPS (TTM)
-3.0600 - Earnings Date Jul 30, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
3.40
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. It provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances, as well as lipids. The company was incorporated in 2020 and is based in Paris, France.
www.euroapi.com/en3,650
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: EAPI.PA
View MorePerformance Overview: EAPI.PA
Trailing total returns as of 9/13/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EAPI.PA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EAPI.PA
View MoreValuation Measures
Market Cap
412.49M
Enterprise Value
593.89M
Trailing P/E
8.29
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.43
Price/Book (mrq)
0.46
Enterprise Value/Revenue
0.61
Enterprise Value/EBITDA
46.76
Financial Highlights
Profitability and Income Statement
Profit Margin
-29.58%
Return on Assets (ttm)
0.03%
Return on Equity (ttm)
-27.59%
Revenue (ttm)
971.3M
Net Income Avi to Common (ttm)
-287.3M
Diluted EPS (ttm)
-3.0600
Balance Sheet and Cash Flow
Total Cash (mrq)
282.8M
Total Debt/Equity (mrq)
53.02%
Levered Free Cash Flow (ttm)
243.89M